| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930412 | Cytotherapy | 2014 | 19 Pages |
Abstract
Our robust, validated and approved protocol for DC manufacturing forms the basis for a harmonized procedure to produce cancer vaccines, which paves the way for larger multi-center clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Matthias Eyrich, Susanne C. Schreiber, Johannes Rachor, Jürgen Krauss, Femke Pauwels, Johannes Hain, Matthias Wölfl, Manfred B. Lutz, Steven de Vleeschouwer, Paul G. Schlegel, Stefaan W. Van Gool,